Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


AzurRx BioPharma Announces Positive Interim Data In Phase 2 Clinical Trial Of MS1819 In Combination With PERT


RTTNews | May 13, 2021 07:11AM EDT

07:10 Thursday, May 13, 2021 (RTTNews) - AzurRx BioPharma Announces Positive Interim Data In Phase 2 Clinical Trial Of MS1819 In Combination With PERT

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC